FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206643692> ?p ?o ?g. }

• W4206643692 endingPage "719" @default.
• W4206643692 startingPage "713" @default.
• W4206643692 abstract "Several definitions have attempted to stratify metastatic castrate-sensitive prostate cancer (mCSPC) into low and high-volume states. However, at this time, comparison of these definitions is limited. Here we aim to compare definitions of metastatic volume in mCSPC with respect to clinical outcomes and mutational profiles. We performed a retrospective review of patients with biochemically recurrent or mCSPC whose tumors underwent somatic targeted sequencing. 294 patients were included with median follow-up of 58.3 months. Patients were classified into low and high-volume disease per CHAARTED, STAMPEDE, and two numeric (≤3 and ≤5) definitions. Endpoints including radiographic progression-free survival (rPFS), time to development of castration resistance (tdCRPC), and overall survival (OS) were evaluated with Kaplan–Meier survival curves and log-rank test. The incidence of driver mutations between definitions were compared. Median OS and tdCRPC were shorter for high-volume than low-volume disease for all four definitions. In the majority of patients (84.7%) metastatic volume classification did not change across all four definitions. High volume disease was significantly associated with worse OS for all four definitions (CHAARTED: HR 2.89; p < 0.01, STAMPEDE: HR 3.82; p < 0.01, numeric ≤3: HR 4.67; p < 0.01, numeric ≤5: HR 3.76; p < 0.01) however, were similar for high (p = 0.95) and low volume (p = 0.79) disease across all four definitions. Those with discordant classification tended to have more aggressive clinical behavior and mutational profiles. Patients with low-volume disease and TP53 mutation experienced a more aggressive course with rPFS more closely mirroring high-volume disease. The spectrum of mCSPC was confirmed across four different metastatic definitions for clinical endpoints and genetics. All definitions were generally similar in classification of patients, outcomes, and genetic makeup. Given these findings, the simplicity of numerical definitions might be preferred, especially when integrating metastasis directed therapy. Incorporation of tumor genetics may allow further refinement of current metastatic definitions." @default.
• W4206643692 created "2022-01-25" @default.
• W4206643692 creator A5000156180 @default.
• W4206643692 creator A5001783218 @default.
• W4206643692 creator A5002414848 @default.
• W4206643692 creator A5006355538 @default.
• W4206643692 creator A5008426497 @default.
• W4206643692 creator A5008552473 @default.
• W4206643692 creator A5018645768 @default.
• W4206643692 creator A5019805108 @default.
• W4206643692 creator A5020031098 @default.
• W4206643692 creator A5028957065 @default.
• W4206643692 creator A5039646183 @default.
• W4206643692 creator A5040778833 @default.
• W4206643692 creator A5041615709 @default.
• W4206643692 creator A5054386630 @default.
• W4206643692 creator A5055949265 @default.
• W4206643692 creator A5064878844 @default.
• W4206643692 creator A5066848628 @default.
• W4206643692 creator A5070623757 @default.
• W4206643692 creator A5072952875 @default.
• W4206643692 creator A5077404005 @default.
• W4206643692 creator A5083566572 @default.
• W4206643692 creator A5085318253 @default.
• W4206643692 date "2022-01-11" @default.
• W4206643692 modified "2023-09-27" @default.
• W4206643692 title "Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics" @default.
• W4206643692 cites W1549619413 @default.
• W4206643692 cites W2011957420 @default.
• W4206643692 cites W2137974207 @default.
• W4206643692 cites W2262087934 @default.
• W4206643692 cites W2278392405 @default.
• W4206643692 cites W2567987817 @default.
• W4206643692 cites W2620706965 @default.
• W4206643692 cites W2620746860 @default.
• W4206643692 cites W2732019947 @default.
• W4206643692 cites W2775321189 @default.
• W4206643692 cites W2787804990 @default.
• W4206643692 cites W2888635398 @default.
• W4206643692 cites W2892240038 @default.
• W4206643692 cites W2897236707 @default.
• W4206643692 cites W2904249129 @default.
• W4206643692 cites W2908857416 @default.
• W4206643692 cites W2918876340 @default.
• W4206643692 cites W2939770857 @default.
• W4206643692 cites W2944301866 @default.
• W4206643692 cites W2944403040 @default.
• W4206643692 cites W3009016370 @default.
• W4206643692 cites W3013251573 @default.
• W4206643692 cites W3119850026 @default.
• W4206643692 cites W3129304597 @default.
• W4206643692 cites W3165866348 @default.
• W4206643692 cites W4240340450 @default.
• W4206643692 doi "https://doi.org/10.1038/s41391-021-00484-4" @default.
• W4206643692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35013522" @default.
• W4206643692 hasPublicationYear "2022" @default.
• W4206643692 type Work @default.
• W4206643692 citedByCount "12" @default.
• W4206643692 countsByYear W42066436922022 @default.
• W4206643692 countsByYear W42066436922023 @default.
• W4206643692 crossrefType "journal-article" @default.
• W4206643692 hasAuthorship W4206643692A5000156180 @default.
• W4206643692 hasAuthorship W4206643692A5001783218 @default.
• W4206643692 hasAuthorship W4206643692A5002414848 @default.
• W4206643692 hasAuthorship W4206643692A5006355538 @default.
• W4206643692 hasAuthorship W4206643692A5008426497 @default.
• W4206643692 hasAuthorship W4206643692A5008552473 @default.
• W4206643692 hasAuthorship W4206643692A5018645768 @default.
• W4206643692 hasAuthorship W4206643692A5019805108 @default.
• W4206643692 hasAuthorship W4206643692A5020031098 @default.
• W4206643692 hasAuthorship W4206643692A5028957065 @default.
• W4206643692 hasAuthorship W4206643692A5039646183 @default.
• W4206643692 hasAuthorship W4206643692A5040778833 @default.
• W4206643692 hasAuthorship W4206643692A5041615709 @default.
• W4206643692 hasAuthorship W4206643692A5054386630 @default.
• W4206643692 hasAuthorship W4206643692A5055949265 @default.
• W4206643692 hasAuthorship W4206643692A5064878844 @default.
• W4206643692 hasAuthorship W4206643692A5066848628 @default.
• W4206643692 hasAuthorship W4206643692A5070623757 @default.
• W4206643692 hasAuthorship W4206643692A5072952875 @default.
• W4206643692 hasAuthorship W4206643692A5077404005 @default.
• W4206643692 hasAuthorship W4206643692A5083566572 @default.
• W4206643692 hasAuthorship W4206643692A5085318253 @default.
• W4206643692 hasBestOaLocation W42066436922 @default.
• W4206643692 hasConcept C120665830 @default.
• W4206643692 hasConcept C121332964 @default.
• W4206643692 hasConcept C121608353 @default.
• W4206643692 hasConcept C126322002 @default.
• W4206643692 hasConcept C143998085 @default.
• W4206643692 hasConcept C2779134260 @default.
• W4206643692 hasConcept C2779466945 @default.
• W4206643692 hasConcept C2780192828 @default.
• W4206643692 hasConcept C50382708 @default.
• W4206643692 hasConcept C61511704 @default.
• W4206643692 hasConcept C66339696 @default.
• W4206643692 hasConcept C71924100 @default.
• W4206643692 hasConceptScore W4206643692C120665830 @default.
• W4206643692 hasConceptScore W4206643692C121332964 @default.

• next